India to United States: Vati Export Trade Route

The India to United States Vati corridor is one of India's established pharmaceutical export routes, with 373 shipments documented worth a combined $8.3M USD. The route is dominated by EUGIA PHARMA SPECIALITIES LIMITED, which alone accounts for roughly 45% of all export value, reflecting the consolidated nature of India's vati manufacturing sector.

Across 32 active suppliers, the average shipment value stands at $22.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with vati's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 29.2%, placing it at rank #14 among India's top vati export destinations globally.

On the import side, key buyers of Indian vati in United States include AUROBINDO PHARMA USA INC, LIFESTAR PHARMA LLC, AUROLOGISTICS LLC, (AUROBINDO PHARM and 56 others. AUROBINDO PHARMA USA INC is the single largest importer with 20 shipments valued at $3.1M USD.

India's vati exports to United States are driven primarily by a handful of large-scale manufacturers. EUGIA PHARMA SPECIALITIES LIMITED with 26 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 32 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, MANKIND PHARMA LIMITED, MANKIND PHARMA LTD — together account for 91% of total trade value on this route. The average shipment value of $22.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as timolol maleate ophthalmic solution usp(0.5% w/v as timolol) ( (preservative free) ) ( 60x0.3ml ) ( qty- 11820.000) and dorzolamide hydrochloride and timolol maleate ophthalmic solution 2%/0.5% preservative free(60 s pack)(qty: 5254 packs), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AUROBINDO PHARMA USA INC is the largest importer with 20 shipments worth $3.1M USD — representing 38% of all vati imports from India on this route. A total of 59 buyers are active on this corridor.